Praxis Precision Medicines to Present at 2021 Wedbush PacGrow Healthcare Conference
02 août 2021 09h00 HE
|
Praxis Precision Medicines, Inc.
CAMBRIDGE, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
Praxis Precision Medicines to Present at Upcoming Investor Conferences
06 juil. 2021 09h00 HE
|
Praxis Precision Medicines, Inc.
CAMBRIDGE, Mass., July 06, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
InMed Pharmaceuticals to Present at the 2021 BIO Digital Conference
09 juin 2021 11h30 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a clinical-stage company developing cannabinoid-based...
Morphic to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
18 juin 2020 08h00 HE
|
Morphic Therapeutic
WALTHAM, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment...
Morphic to Present at the Jefferies Virtual Healthcare Conference
27 mai 2020 08h00 HE
|
Morphic Therapeutic
WALTHAM, Mass., May 27, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment...
Morphic Therapeutic to Present at the BofA Securities 2020 Health Care Conference
29 avr. 2020 16h15 HE
|
Morphic Therapeutic
WALTHAM, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment...
Morphic Therapeutic to Present at the 40th Annual Cowen Health Care Conference
28 févr. 2020 08h00 HE
|
Morphic Therapeutic
WALTHAM, Mass., Feb. 28, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment...
Stellar Biotechnologies Announces Biotech Showcase 2012 Presentations
04 janv. 2012 09h10 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jan 4, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) is pleased to announce that it will be making two presentations at...